Physician profile
Chris E Malone
NPI 1679581474
$1,736.04
in general payments reported to CMS, 2019-2025
13 companies · $460 in 2025
The $460 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $99.62 · 2021: $144 · 2022: $170 · 2023: $160 · 2024: $284 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $398.45 | 2021-2025 | Varithena Administration Pack, General - Interventional Oncology |
| Abbvie INC. | $302.32 | 2023-2025 | |
| Medtronic, INC. | $230.24 | 2021-2024 | Venaseal, Closurefast |
| Medtronic Vascular, INC. | $201.19 | 2019-2020 | |
| Tactile Systems Technology INC | $192.75 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Biocompatibles, INC. | $132.99 | 2019 | |
| Heraeus Medical, LLC. | $119.00 | 2019 | |
| Allergan, INC. | $50.34 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $32.55 | 2021-2022 | |
| Cashflow Solutions, LLC | $21.74 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Pfizer INC. | $20.94 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.43 | 2023 | Exparel, Iovera, Zilretta |
| Astrazeneca Pharmaceuticals Lp | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.